Previous studies have shown that the frequency of CD169+ monocytes is associated with the disease activity in autoimmune diseases, such as systemic sclerosis [23], systemic lupus erythematosus [24] and rheumatoid arthritis [25]. This evidence concerns the gene SIGLEC1 and systemic sclerosis.